Skip to content
No results
  • About
  • Services
    • Regulatory Affairs
    • Quality and Compliance
    • Clinical Trial Operations
    • Pharmacovigilance and Safety
  • Newsroom
    • Strategic Insight
    • Regulatory Updates
    • From Our Desk
  • Careers
  • Contact Us
GH StrategiesGH Strategies
  • About
  • Services
    • Regulatory Affairs
    • Quality and Compliance
    • Clinical Trial Operations
    • Pharmacovigilance and Safety
    • Training and Capacity Building
    • Strategic Advisory and Business Consulting
  • Newsroom
    • Strategic Insight
    • Regulatory Updates
    • From Our Desk
  • Careers
Contact Us
GH StrategiesGH Strategies
Launching the GH Strategies Institute
  • From Our Desk

Launching the GH Strategies Institute: Empowering Pharma and MedTech Professionals Through e-Learning

There are moments in every industry when progress demands a new way of thinking. For…

  • ByGH Strategies
  • On15 Dec 2025
  • From Our Desk

Strengthening Pharmacovigilance Systems: GH Strategies’ Vision for Safer Healthcare

Every medicine, vaccine, and medical device carries the promise of better health, but also the…

  • ByGH Strategies
  • On9 Dec 2025
SAHPRA Requires ISO 13485 Certification for Medical Device Establishment Licences in South Africa
  • Regulatory Updates

SAHPRA Requires ISO 13485 Certification for Medical Device Establishment Licences in South Africa

In April 2025, the South African Health Products Regulatory Authority (SAHPRA) formally announced that medical…

  • ByGH Strategies
  • On2 Dec 2025
Optimising the Clinical Supply Chain GH Strategies’ Role in Global Trial Readiness from South Africa
  • From Our Desk

Optimising the Clinical Supply Chain: GH Strategies’ Role in Global Trial Readiness from South Africa

Clinical trials depend on precision – not only in research design but also in how…

  • ByGH Strategies
  • On12 Nov 2025
Person in lab coat holding documents
  • Strategic Insight

Mastering Inspection Readiness: How South African Pharma & MedTech Companies Can Stay Audit-Ready

Inspection readiness has become one of the most critical success factors for pharmaceutical, biotech, and…

  • ByGH Strategies
  • On11 Nov 2025
GMP Audit - Image
  • Strategic Insight

Top 7 GMP Audit Failures in South African Pharma Companies (and How to Prevent Them)

South Africa’s pharmaceutical and clinical research sector has grown rapidly over the last decade. The…

  • ByGH Strategies
  • On14 Oct 2025
1 2 3 4Next
No more posts to load
No results

Posts

Medicines and Medical Devices Under South African Law

24 Feb 2025
GMP Audit - Image

Top 7 GMP Audit Failures in South African Pharma Companies (and How to Prevent Them)

14 Oct 2025
ISO 13485 - Image

Why ISO 13485 Is the Backbone of South African MedTech Compliance

16 Sep 2025

How GCP Training Strengthens Clinical Research in South Africa

13 May 2025

Why Good Distribution Practice (GDP) Protects South Africa’s Pharma Supply Chain

15 Jul 2025

We work alongside our clients to strengthen regulatory, quality, and safety systems, helping them operate with confidence and protect the people who rely on them.

Gordon Hakala, M. Pharm

About Us

GH Strategies is a regulatory, quality, and strategic consulting company supporting pharmaceutical, medical device, and biotech organisations across South Africa and Africa.

  • Office: 1262 Embankment Rd, Centurion, 0157
  • Phone: 010 140 4294
  • Email: engage@ghstrategies.co.za

Areas of Expertise

  • Regulatory Affairs
  • Quality & Compliance
  • Clinical Trial Operations
  • Pharmacovigilance
  • Strategic Advisory
  • Training & Capacity Building

Insights & News

  • Strategic Insights
  • From Our Desk
  • Resource Library

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Copyright © 2026 - GH Strategies. All Rights Reserved

Cookie Notice

We use cookies to enhance your browsing experience and to help us improve our services. You may accept all cookies, allow only essential cookies, or manage your preferences.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View Settings
  • {title}
  • {title}
  • {title}